Norway – Mitsubishi Heavy Industries Engineering (MHIENG), part of the Mitsubishi Heavy Industries (MHI) Group, has entered into an agreement with the Technology Center Mongstad (TCM) to test its patented CO2 capture solvent at an amine plant located in Mongstad, Norway.
The patented solvent to be tested is KS-21TM, an amine-based adsorbent used in the newly produced “Advanced KM CDR ProcessTM” developed by MHIENG in partnership with Kansai Electric Power (KEPCO). Its long-term use will be illustrated in Norway, one of the most mature countries in the world with regard to environmental restrictions on CO2 capture, in an effort to achieve commercialization by 2021. Compared to the previous KS-1TM solvent, which was used in 13 commercial plants delivered by MHIENG, KS-21TM has a range of beneficial properties, such as lower volatility and greater degradation stability. The newer solvent is also expected to enable reduced running costs and other economic benefits.
CO2 capture expanding
At a time when CO2 capture needs are expanding in the United Kingdom and Europe, the TCM test program, which has state-of-the-art facilities and advanced expertise, will validate KS-21TM’s long-term reliability and determine its environmental effects, while providing MHIENG with technical evidence on its substantially higher carbon capture rate. The test program would enable MHIENG to set a timeline for the commercialization of KS-21TM, paving the door for the company to increase orders on the UK and European markets.
After its establishment in 2012, TCM, fitted with the world’s largest CO2 catch testing facility, has provided consumers with extensive expertise, online research, and innovative analytical technology for trace components of gas emissions. Its data collected by research exceeds 1,000 categories and greatly contributes to the commercialization of absorbents.
